It's amazing that one in such position can be compensated so much for such poor stock performance......even as the leadership door revolves with hopeful after hopeful....only to see the pps/mc sink miserably. I suppose that's the norm in biotech?
And, if so, yet another reason for retail to stop and think twice...and know that Cash is King, and when ya have it, it feels good.
And when ya see it pissed away after jumpin' onboard, not so good.
Jmho
News 
Market Data 
Discover 
